FHIR R4 EffectEvidenceSynthesis API

(0 reviews)
The EffectEvidenceSynthesis resource describes the difference in an outcome between exposures states in a population where the effect estimate is derived from a combination of research studies.

home

Overview

This asset is a component of MuleSoft Accelerator for Healthcare.

MuleSoft Accelerator for Healthcare enables healthcare providers to unlock critical patient data to build a patient 360 within Salesforce Health Cloud, faster and easier than ever before. The solution includes pre-built APIs, connectors, integration templates, and prescriptive end-to-end reference architecture to bring patient demographics information and COVID-19 test results from any EHR into Health Cloud using HL7 V2 or FHIR standards.

The solution also provides a library of United States Core Data for Interoperability (USCDI) and FHIR R4 resources to help healthcare developers adhere to interoperability needs and jumpstart the development of healthcare digital transformation initiatives.

Use case covered

The scope of the EffectEvidenceSynthesis resource is to describe the estimates of an effect of an exposure on an outcome where the effect estimates are derived from the combination of research studies. Effect estimates are a measure of difference between the exposure state and an alternative exposure state (often called the control or comparator state) Expressing effect estimates is done throughout reporting of biomedical research, systematic reviews, and clinical reference across all disciplines.

This API uses FHIR R4 EffectEvidenceSynthesis Library.

More information about FHIR R4 EffectEvidenceSynthesis specification can be found here.


Reviews

TypeREST API
OrganizationMuleSoft
Published by
MuleSoft Organization
Published onJul 23, 2020
Asset overview

Asset versions for 1.0.x

Asset versions
VersionActions
1.0.0

Categories

Accelerator
HealthcareNo values left to add
Industry Vertical
HealthcareNo values left to add

Tags